Tradestie Institutional Equity Comparison Engine

CRSP vs ADMA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADMA Overall Edge

ADMA Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ADMA Biologics, Inc. (ADMA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CRSP trades at 23.4x Forward P/E with -2058.6% operating margin (+1325.1% YoY revenue) versus ADMA at 15.7x Forward P/E and 44.9% operating margin (+5.1% YoY). In options structure, CRSP sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against ADMA sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ADMA
CRSP 23.4x vs ADMA 15.7x Fwd P/E
Growth & Margin Winner ADMA
Op Margin -2058.6% vs 44.9% ยท YoY +1325.1% vs +5.1%
Momentum & Technical Winner ADMA
1Y -20.5% vs -12.8% ยท 52W Pos 1% vs 49%
Options & Structure Winner ADMA
BREAKDOWN (52nd %ile IV) vs SURGE (8th %ile IV)
CRSP NASDAQ
CRISPR Therapeutics AG
Biological Products, (No Disgnostic Substances)
$40.61
-3.86% 1D
Market Cap $4.1B
1M Return -17.54%
1Y Return -20.54%
Forward P/E 23.4x
Unified AI Score
48.6 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 68.0 Mom 60.0
ADMA NASDAQ
ADMA Biologics, Inc.
Biological Products, (No Disgnostic Substances)
$13.70
+0.11% 1D
Market Cap $2.9B
1M Return +28.23%
1Y Return -12.77%
Forward P/E 15.7x
Unified AI Score
26.5 / 100 SELL
Tech 15.0 Fund 35.0 Flow 66.0 Mom 25.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRSP -20.54% ADMA -12.77% Spread: +7.77 pp (ADMA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CRSP Revenue ADMA Revenue CRSP Op. Margin ADMA Op. Margin Margin Edge
FY2018 $0M $20M -5087.8% -354.9% ADMA
FY2019 $290M $30M 16.1% -141.1% CRSP
FY2020 $0M $40M -49295.5% -153.8% ADMA
FY2021 $910M $80M 40.8% -72.1% CRSP
FY2022 $0M $150M -56190.4% -25.5% ADMA
FY2023 $370M $260M -60.0% 8.4% ADMA
FY2024 $40M $430M -1250.4% 32.6% ADMA
FY2025 $0M $510M -18933.6% 37.5% ADMA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRSP (4) vs ADMA (6)
Institutional Metric CRSP ADMA Criterion Row Winner
Market Capitalization Scale $4.1B $2.9B Larger Scale CRSP
Trailing P/E Ratio Valuation 23.4x 17.2x Lower Multiple ADMA
Forward P/E Ratio Valuation 23.4x 15.7x Lower Multiple ADMA
Revenue Growth (YoY) Growth +1325.1% +5.1% Higher Growth CRSP
Operating Margin (TTM) Profitability -2058.6% 44.9% Higher Margin ADMA
Net Profit Margin Profitability 0.0% 35.1% Higher Margin ADMA
Return on Equity (ROE) Capital Efficiency -25.6% 41.9% Higher ROE ADMA
52-Week Range Position Momentum 1% ($40โ€“$63) 49% ($7โ€“$20) Stronger Trend ADMA
Beta / 30D Volatility Risk Regime 1.85ฮฒ ยท 60% Vol -0.42ฮฒ ยท 99% Vol Lower Realized Risk CRSP
Unified Institutional Score Composite Signal 48.6 / 100 (HOLD) 26.5 / 100 (SELL) Higher Composite CRSP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRSP vs ADMA Buy Guide
CRSP BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CRSP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADMA SURGE
7d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ADMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRSP nor ADMA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.